BioHealth Innovation, Inc. (BHI), a regional innovation intermediary focused on commercializing market-relevant bio-health innovations and increasing access to early-stage funding in Maryland, has been awarded a renewal of its contract to extend and expand its entrepreneur-in-residence (EIR) program with the National Institutes of Health (NIH). BHI will place EIRs within the National Heart, Lung and Blood Institute (NHLBI), the NIH Office of the Director and other NIH Institutes and Centers.
{iframe}http://www.military-technologies.net/2017/04/10/nih-extends-contract-to-biohealth-innovation-to-further-expand-entrepreneur-in-residence-program-established-in-2012/{/iframe}